Stephens analyst Jeff Garro downgraded Evolent Health (EVH) to Equal Weight from Overweight with a $16 price target
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- Evolent Health Reports Revenue Growth Amid Challenges
- Closing Bell Movers: Toast gains 19% afterhours after earnings beat
- Evolent Health sees FY24 revenue $2.55B-$2.575B, consensus $2.58B
- Evolent Health reports Q3 adjusted EPS 4c, consensus 34c
- Evolent Health sees Q4 revenue $642M-$667M, consensus $663.03M